Evidence map›Paper›PMID 36661817›Full record

ArticleGels (Basel, Switzerland)2023

Assessing Polysaccharides/Aloe Vera-Based Hydrogels for Tumor Spheroid Formation.

Petruța Preda, Ana-Maria Enciu, Cristiana Tanase, Maria Dudau, Lucian Albulescu, Monica-Elisabeta Maxim, Raluca Nicoleta Darie-Niță, Oana Brincoveanu, Marioara Avram

Open access · goldAbstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Natural Regenerative Hydrogels for Wound Healing.Gels (Basel, Switzerland) · 2024
    Review
  4. Patterned PVA Hydrogels with 3D Petri DishGels (Basel, Switzerland) · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Petruța PredaNational Institute for Research and Development in Microtechnologies-IMT Bucharest, 126A Erou Iancu Nicolae, 077190 Bucharest, Romania.
Ana-Maria EnciuBiochemistry-Proteomics Department, Victor Babes National Institute of Pathology, 99-101 Splaiul Ind Pendentei, 050096 Bucharest, Romania.
Cristiana TanaseBiochemistry-Proteomics Department, Victor Babes National Institute of Pathology, 99-101 Splaiul Ind Pendentei, 050096 Bucharest, Romania.
Maria DudauBiochemistry-Proteomics Department, Victor Babes National Institute of Pathology, 99-101 Splaiul Ind Pendentei, 050096 Bucharest, Romania.ORCID 0000-0002-5071-9756
Lucian AlbulescuBiochemistry-Proteomics Department, Victor Babes National Institute of Pathology, 99-101 Splaiul Ind Pendentei, 050096 Bucharest, Romania.
Monica-Elisabeta Maxim"Ilie Murgulescu" Institute of Physical Chemistry, Romanian Academy, Spl. Independentei 202, 060021 Bucharest, Romania.
Raluca Nicoleta Darie-NițăPhysical Chemistry of Polymers Department, Petru Poni Institute of Macromolecular Chemistry, 41A Grigore Ghica Voda Alley, 700487 Iasi, Romania.ORCID 0000-0001-9184-3860
Oana BrincoveanuNational Institute for Research and Development in Microtechnologies-IMT Bucharest, 126A Erou Iancu Nicolae, 077190 Bucharest, Romania.
Marioara AvramNational Institute for Research and Development in Microtechnologies-IMT Bucharest, 126A Erou Iancu Nicolae, 077190 Bucharest, Romania.ORCID 0000-0002-4126-7401
National Institute for Research and Development in Microtechnologies · ROInstitutul National Victor Babes · ROCarol Davila University of Medicine and Pharmacy · ROInstitutul de Chimie Macromoleculară Petru PoniRomanian Academy · ROTitu Maiorescu University · RO

Funding

Agency for Higher Education, Research, Development and Innovation (UEFISCDI). PN-III-P2-2.1-PED-2021-3112 project (Grant No. 597PED ⁄ 2022)
6 · The paper itself

Abstract

In vitro tumor spheroids have proven to be useful 3D tumor culture models for drug testing, and determining the molecular mechanism of tumor progression and cellular interactions. Therefore, there is a continuous search for their industrial scalability and routine preparation. Considering that hydrogels are promising systems that can favor the formation of tumor spheroids, our study aimed to investigate and develop less expensive and easy-to-use amorphous and crosslinked hydrogels, based on natural compounds such as sodium alginate (NaAlg), aloe vera (AV) gel powder, and chitosan (CS) for tumor spheroid formation. The ability of the developed hydrogels to be a potential spheroid-forming system was evaluated using MDA-MB-231 and U87MG cancer cells. Spheroid abilities were influenced by pH, viscosity, and crosslinking of the hydrogel. Addition of either AV or chitosan to sodium alginate increased the viscosity at pH 5, resulting in amorphous hydrogels with a strong gel texture, as shown by rheologic analysis. Only the chitosan-based gel allowed formation of spheroids at pH 5. Among the variants of AV-based amorphous hydrogels tested, only hydrogels at pH 12 and with low viscosity promoted the formation of spheroids. The crosslinked NaAlg/AV, NaAlg/AV/glucose, and NaAlg/CS hydrogel variants favored more efficient spheroid formation. Additional studies would be needed to use AV in other physical forms and other formulations of hydrogels, as the current study is an initiation, in evaluating the potential use of AV gel in tumor spheroid formation systems.

Indexed as

aloe vera gelhydrogelnatural polymerpolysaccharidestumor spheroids

Identifiers

PMID36661817
PMCPMC9858450
OpenAlexW4313828754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.